2021
DOI: 10.3389/fneur.2020.635612
|View full text |Cite
|
Sign up to set email alerts
|

Editorial: Corticospinal Excitability in Patients With Multiple Sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 6 publications
0
3
0
Order By: Relevance
“…Using navigated transcranial magnetic stimulation (TMS) in probing corticospinal excitability as a marker of functional integrity of the primary motor cortex (M1), corticospinal axonal pathway, and peripheral signaling function to target muscles could help in further understanding the underlying pathophysiological mechanisms of MS. Recent findings proposed that applying TMS as an adjuvant para-clinical instrument could help to identify biomarkers of the MS disease [8], serving as a biomarker of MS disability [9]. An association between the pathophysiological mechanisms of MS (demyelination and axonal loss) and TMS measures (e.g., low amplitudes and prolonged latencies of motor evoked potentials (MEP), increased resting motor threshold (RMT), and increased central motor conduction time) have been reported [6].…”
Section: Multiple Sclerosis (Ms) Is An Inflammatory Autoimmune-mediat...mentioning
confidence: 99%
“…Using navigated transcranial magnetic stimulation (TMS) in probing corticospinal excitability as a marker of functional integrity of the primary motor cortex (M1), corticospinal axonal pathway, and peripheral signaling function to target muscles could help in further understanding the underlying pathophysiological mechanisms of MS. Recent findings proposed that applying TMS as an adjuvant para-clinical instrument could help to identify biomarkers of the MS disease [8], serving as a biomarker of MS disability [9]. An association between the pathophysiological mechanisms of MS (demyelination and axonal loss) and TMS measures (e.g., low amplitudes and prolonged latencies of motor evoked potentials (MEP), increased resting motor threshold (RMT), and increased central motor conduction time) have been reported [6].…”
Section: Multiple Sclerosis (Ms) Is An Inflammatory Autoimmune-mediat...mentioning
confidence: 99%
“…Multimodal Eps, such as somatosensory evoked potentials (SEPs), visual evoked potentials (VEPs), and motor evoked potentials (MEPs), recorded as baseline (at diagnosis), have been shown to correlate with EDSS [ 12 ]. Recent findings suggest the likely application of TMS as a subclinical MEP test that could represent a biomarker of the degree of MS disability [ 13 , 14 ]. Current data suggest a connection between the pathophysiological mechanisms of MS (demyelination and loss of axons) and TMS neurophysiological measures (e.g., lower amplitudes and longer latencies of MEP responses from upper and lower limb muscles, elevated resting motor threshold (RMT), and changes in specific neurophysiological measures of excitation and inhibition) [ 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…Motor-evoked potentials (MEPs) represent neurophysiological measures of signal conduction in the CNS in vivo. Examining corticospinal excitability as a marker of functional integrity of the primary motor cortex (M1) and the corticospinal pathway using e-filed navigated transcranial magnetic stimulation (TMS) by assessing MEP could elucidate the underlying pathophysiological mechanisms of MS [16,17,[19][20][21].…”
Section: Introductionmentioning
confidence: 99%